2 years ago
PGNY
AnalystsScott SchoenhausScott Schoenhaus's Stock Forecasts
AnalystsScott Schoenhaus
Analyst Ranking
Bottom 5%
#4857 out of 5069 analysts
Average Return
-4.54%
Win Rate
40%44 out of 110
Risk vs Reward
Poor
Good
Scott Schoenhaus's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Abcellera Biologics IncABCL | +133.89% | $2.39 | $5.59 | 2025-04-16 - 2025-10-17 | Strong Buy |
Lifemd IncLFMD | +91.05% | $6.26 | $11.96 | 2024-07-11 - 2025-07-10 | Strong Buy |
Abcellera Biologics IncABCL | +84.49% | $3.03 | $5.59 | 2025-01-08 - 2025-10-17 | Strong Buy |
R1 Rcm IncRCM | +57.10% | $6.90 | $10.84 | 2022-11-09 - 2023-11-08 | Strong Buy |
Benefitfocus IncBNFT | +55.94% | $6.65 | $10.37 | 2022-09-16 - 2022-11-08 | Strong Buy |
Scott Schoenhaus Analyst Color
Get additional color on Scott Schoenhaus's coverage of popular stocks
2 years ago
RXRX
2 years ago
OMCL
2 years ago
VEEV
2 years ago
OMCL
3 years ago
PHR
Scott Schoenhaus's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tenet Healthcare CorpTHC | 1 | Strong Buy | $225.00 | +12.50% | Maintains | 12 days ago |
Schrodinger IncSDGR | 6 | Strong Buy | $28.00 | +45.00% | Maintains | 12 days ago |
Phreesia IncPHR | 8 | Strong Buy | $32.00 | +43.56% | Maintains | 12 days ago |
Oddity Tech LtdODD | 4 | Strong Buy | $80.00 | +57.33% | Maintains | 12 days ago |
Healthequity IncHQY | 6 | Strong Buy | $120.00 | +31.20% | Maintains | 12 days ago |
Health Catalyst IncHCAT | 6 | Strong Buy | $4.00 | +31.15% | Maintains | 12 days ago |
Doximity IncDOCS | 5 | Strong Buy | $80.00 | +18.40% | Maintains | 12 days ago |
Certara IncCERT | 5 | Strong Buy | $16.00 | +33.67% | Maintains | 12 days ago |
Lifemd IncLFMD | 4 | Strong Buy | $12.00 | +97.37% | Maintains | 2 months ago |
Simulations Plus IncSLP | 4 | Strong Buy | $25.00 | +62.34% | Maintains | 3 months ago |
Hinge Health IncHNGE | 2 | Strong Buy | $60.00 | +21.75% | Maintains | 3 months ago |
Eastman Chemical CoEMN | 1 | Strong Buy | $93.00 | +51.76% | Maintains | 3 months ago |
Albemarle CorpALB | 1 | Strong Buy | $87.00 | -6.19% | Maintains | 3 months ago |
Abcellera Biologics IncABCL | 6 | Strong Buy | $10.00 | +78.89% | Maintains | 3 months ago |
Absci CorpABSI | 6 | Strong Buy | $9.00 | +98.68% | Maintains | 6 months ago |
Veeva Systems IncVEEV | 11 | Strong Buy | $255.00 | -10.13% | Maintains | 9 months ago |
Recursion Pharmaceuticals IncRXRX | 6 | Strong Buy | $10.00 | +70.65% | Maintains | 9 months ago |
Goodrx Holdings IncGDRX | 4 | Strong Buy | $6.00 | +56.66% | Maintains | 9 months ago |
Talkspace IncTALK | 1 | Strong Buy | $4.50 | +63.04% | Initiates Coverage On | 10 months ago |
Alight IncALIT | 6 | Strong Buy | $11.00 | +270.37% | Maintains | a year ago |
R1 Rcm IncRCM | 7 | Strong Buy | $17.00 | N/A | Maintains | 2 years ago |
Progyny IncPGNY | 4 | Strong Buy | $45.00 | N/A | Maintains | 2 years ago |
Omnicell IncOMCL | 7 | Strong Buy | $75.00 | N/A | Maintains | 2 years ago |
Benefitfocus IncBNFT | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Veradigm IncMDRX | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Teladoc Health IncTDOC | 2 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Iqvia Holdings IncIQV | 1 | Strong Buy | $250.00 | N/A | Upgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.